Harrow Health Inc. (HROW)
28.97
-1.16 (-3.85%)
At close: Feb 21, 2025, 3:59 PM
28.95
-0.07%
After-hours: Feb 21, 2025, 04:00 PM EST
Harrow Health Income Statement
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| Revenue | 130.19M | 88.59M | 72.48M | 48.87M | 51.16M | 41.37M | 26.77M | 19.94M | 9.72M | 1.66M | 10K | 100K | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 39.64M | 25.38M | 18.21M | 14.46M | 16.75M | 16.52M | 13.51M | 9.83M | 5.21M | 1.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 90.55M | 63.21M | 54.26M | 34.41M | 34.42M | 24.85M | 13.27M | 10.11M | 4.51M | 567.41K | 10K | 100K | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | 431K | -1.75M | -284K | -1.63M | -503K | -5.22M | -12.16M | -15.88M | -14.82M | -10.15M | -7.69M | -4.18M | -939.23K | -2.5M | -4.56M | -3.75M | -2.86M | -46.21K |
| Interest Income | n/a | 7.24M | 5.44M | 2.24M | n/a | n/a | n/a | 10K | 13K | 32.45K | 43.76K | 15.41K | n/a | 512.00 | 10.44K | 67.01K | 48.44K | n/a |
| Pretax Income | -23.71M | -14.01M | -17.87M | -3.42M | -125K | 14.63M | -12.92M | -19.2M | -15.9M | -10.12M | -7.64M | -5.38M | -953.94K | -2.53M | n/a | -3.37M | -2.77M | -580K |
| Net Income | -24.41M | -14.09M | -18.01M | -3.42M | -2.59M | 14.63M | -11.98M | -19.09M | -15.9M | -10.12M | -7.64M | -5.38M | -953.94K | -2.53M | -4.55M | -3.3M | -4.28M | -46.21K |
| Selling & General & Admin | 83.09M | 58.24M | 41.31M | 31.25M | 33.1M | 29.24M | 25.02M | 24.95M | 19M | 10.48M | 6.08M | 2.98M | 827.67K | 2.31M | 1.6M | 1.76M | 2.86M | 6.21K |
| Research & Development | 6.65M | 3.05M | 11.08M | 2.41M | 2.08M | 825K | 413K | 739K | 332K | 236.66K | 1.62M | 1.3M | 111.55K | 194.59K | 2.97M | 1.99M | 1.83M | 150K |
| Other Expenses | 380K | -15.93M | -19.49M | -3.8M | 630K | 103K | n/a | 1.54M | 31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -110K |
| Operating Expenses | 90.12M | 61.29M | 52.4M | 33.66M | 35.18M | 30.07M | 25.43M | 25.69M | 19.33M | 10.71M | 7.7M | 4.28M | 939.23K | 2.5M | 4.56M | 3.75M | 2.86M | 46.21K |
| Interest Expense | 21.32M | 7.24M | 5.44M | 2.24M | 2.5M | 2.73M | 3.03M | 6M | 1.12M | 3.8K | n/a | 24.66K | 75K | 55.48K | n/a | n/a | 1.56M | -10K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 7.06M | 7.38M | 6.5M | 2.39M | 85.89K | n/a | n/a | n/a | n/a | n/a | n/a | -423.79K |
| Cost & Expenses | 129.76M | 86.68M | 70.61M | 48.12M | 51.93M | 46.59M | 38.94M | 35.52M | 24.54M | 11.81M | 7.7M | 4.28M | 939.23K | 2.5M | 4.56M | 3.75M | 2.86M | 46.21K |
| Income Tax | 701K | 75K | 133K | 4K | 2.47M | -19.45M | -935K | -111K | 1.08M | -28.65K | -43.76K | 1.2M | -60.29K | -26.3K | -10.44K | -817.01K | -228.27K | 10K |
| Shares Outstanding (Basic) | 32.62M | 27.46M | 26.76M | 25.9M | 25.32M | 23.81M | 19.98M | 12.74M | 9.58M | 9.13M | 8.66M | 4.49M | 397.8K | 394.63K | 390.32K | 370.55K | 221.17K | 185.01K |
| Shares Outstanding (Diluted) | 32.62M | 27.46M | 26.76M | 25.9M | 26.47M | 23.81M | 20.03M | 12.74M | 9.58M | 9.13M | 8.66M | 4.49M | 397.8K | 394.63K | 390.32K | 370.55K | 221.17K | 185.01K |
| EPS (Basic) | -0.75 | -0.51 | -0.67 | -0.13 | -0.1 | 0.61 | -0.6 | -1.5 | -1.66 | -1.11 | -0.88 | -1.2 | -2.4 | -6.41 | -11.67 | -8.92 | -19.37 | -0.25 |
| EPS (Diluted) | -0.75 | -0.51 | -0.67 | -0.13 | -0.1 | 0.61 | -0.6 | -1.5 | -1.66 | -1.11 | -0.88 | -1.2 | -2.4 | -6.41 | -11.67 | -8.92 | -19.37 | -0.25 |
| EBITDA | 9.72M | -3.2M | -10.14M | 3.49M | 1.44M | -2.73M | -10.4M | -14.06M | -14.21M | -10.06M | -7.64M | -5.36M | -878.6K | -2.47M | -4.55M | -4.12M | -2.75M | -46.21K |
| Depreciation & Amortization | 12.34M | 3.67M | 2.4M | 2.74M | 2.66M | 1.84M | 1.76M | 1.41M | 610K | 85.35K | 5.66K | 2.94K | 338.00 | 1.06K | 1.06K | 704.00 | 201.25K | n/a |